References
Zahniser NR, Sorkin A . Neuropharmacology 2004; 47: 80–91.
Guindalini C, Howard M, Larajeira R, Collier D, Ammar N, Craig I et al. Proc Natl Acad Sci USA 2006; 103: 4552–4557.
Volkow ND . J Nucl Med 2004; 45: 13N–16N, 19N–20N, 22N passim.
Schoenbaum G, Roesch MR, Stalnaker TA . Trends Neurosci 2006; 29: 116–124.
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Nature 1996; 379: 606–612.
Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K et al. Am J Psychiatry 2003; 160: 1699–1701.
Volkow ND, Chang L, Wang GL, Fowler JS, Ding YS, Sedler M et al. Am J Psychiatry 2001; 158: 2015–2021.
Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A et al. Am J Psychiatry 1999; 156: 1440–1443.
Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS et al. J Neurosci 2005; 25: 3932–3939.
Bellgrove MA, Chambers CD, Johnson KA, Daibhis A, Daly M, Hawi Z et al. Mol Psychiatry 2007; 12: 786–792.
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Brotons, O., O'Daly, O., Guindalini, C. et al. Modulation of orbitofrontal response to amphetamine by a functional variant of DAT1 and in vitro confirmation. Mol Psychiatry 16, 124–126 (2011). https://doi.org/10.1038/mp.2009.6
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2009.6
- Springer Nature Limited
This article is cited by
-
Characterisation of the potential function of SVA retrotransposons to modulate gene expression patterns
BMC Evolutionary Biology (2013)